172 related articles for article (PubMed ID: 33795792)
21. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants.
Ohlsson A; Shah PS
Cochrane Database Syst Rev; 2015 Mar; (3):CD010061. PubMed ID: 25758061
[TBL] [Abstract][Full Text] [Related]
22. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2010 Apr; (4):CD003481. PubMed ID: 20393936
[TBL] [Abstract][Full Text] [Related]
23. Oral ibuprofen is superior to oral paracetamol for patent ductus arteriosus in very low and extremely low birth weight infants.
Lu J; Li Q; Zhu L; Chen C; Li Z
Medicine (Baltimore); 2019 Aug; 98(31):e16689. PubMed ID: 31374055
[TBL] [Abstract][Full Text] [Related]
24. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.
Heyman E; Morag I; Batash D; Keidar R; Baram S; Berkovitch M
Pediatrics; 2003 Nov; 112(5):e354. PubMed ID: 14595076
[TBL] [Abstract][Full Text] [Related]
25. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Shah SS; Ohlsson A
Cochrane Database Syst Rev; 2006 Jan; (1):CD004213. PubMed ID: 16437478
[TBL] [Abstract][Full Text] [Related]
26. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
[TBL] [Abstract][Full Text] [Related]
27. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Shah SS; Ohlsson A
Cochrane Database Syst Rev; 2003; (2):CD004213. PubMed ID: 12804505
[TBL] [Abstract][Full Text] [Related]
28. Baseline cardiac output and its alterations during ibuprofen treatment for patent ductus arteriosus in preterm infants.
Hsu KH; Wu TW; Wu IH; Lai MY; Hsu SY; Huang HW; Mok TY; Lee CC; Lien R
BMC Pediatr; 2019 Jun; 19(1):179. PubMed ID: 31167645
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Neurodevelopment of Low-Birthweight, Preterm Infants with Patent Ductus Arteriosus.
Collins RT; Lyle RE; Rettiganti M; Gossett JM; Robbins JM; Casey PH
J Pediatr; 2018 Dec; 203():170-176.e1. PubMed ID: 30268404
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized controlled trial.
El-Farrash RA; El Shimy MS; El-Sakka AS; Ahmed MG; Abdel-Moez DG
J Matern Fetal Neonatal Med; 2019 Nov; 32(21):3647-3654. PubMed ID: 29695206
[No Abstract] [Full Text] [Related]
31. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.
El-Mashad AE; El-Mahdy H; El Amrousy D; Elgendy M
Eur J Pediatr; 2017 Feb; 176(2):233-240. PubMed ID: 28004188
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of Oral Versus Intravenous Ibuprofen Therapy in Preterm Infants With Patent Ductus Arteriosus in the Neonatal Intensive Care Setting: A Cohort-based Study.
Abushanab D; Rouf PA; Al Hail M; Kamal R; Viswanathan B; Parappil H; Elkassem W; Al-Shaibi S; Al-Badriyeh D
Clin Ther; 2021 Feb; 43(2):336-348.e7. PubMed ID: 33431169
[TBL] [Abstract][Full Text] [Related]
33. Long-term neurodevelopmental outcomes in very low birth weight infants with and without patent ductus arteriosus: A retrospective case control observational study.
Elbayiyev S; Canpolat FE; Kadıoğlu Şimşek G; Işık S; Büyüktiryaki M; Kanmaz Kutman HG
Child Care Health Dev; 2022 Sep; 48(5):862-868. PubMed ID: 35274341
[TBL] [Abstract][Full Text] [Related]
34. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
Hirt D; Van Overmeire B; Treluyer JM; Langhendries JP; Marguglio A; Eisinger MJ; Schepens P; Urien S
Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness and safety of rectal dexibuprofen versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants with gestational age<34 weeks: A pilot study.
Pan JJ; Yang Y; Cui SD; Chen XQ; Zhou XG
Int J Immunopathol Pharmacol; 2023; 37():3946320231152993. PubMed ID: 36744872
[TBL] [Abstract][Full Text] [Related]
36. Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure.
Roofthooft DW; van Beynum IM; de Klerk JC; van Dijk M; van den Anker JN; Reiss IK; Tibboel D; Simons SH
Eur J Pediatr; 2015 Nov; 174(11):1433-40. PubMed ID: 25922139
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of Dual Medication Therapy (Oral Acetaminophen and Oral Ibuprofen) for the Management of Patent Ductus Arteriosus in Extremely Premature Infants: A Feasibility Trial.
Shah SD; Makker K; Nandula P; Smotherman C; Kropf A; Hudak ML
Am J Perinatol; 2022 Sep; 39(12):1326-1333. PubMed ID: 33454945
[TBL] [Abstract][Full Text] [Related]
38. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants.
Gouyon JB; Kibleur Y
Clin Ther; 2010 Sep; 32(10):1740-8. PubMed ID: 21194597
[TBL] [Abstract][Full Text] [Related]
40. The Effect of Oral High-dose Ibuprofen on Patent Ductus Arteriosus Closure in Preterm Infants.
Pourarian S; Takmil F; Cheriki S; Amoozgar H
Am J Perinatol; 2015 Oct; 32(12):1158-63. PubMed ID: 26007314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
